Richter Heiko, Seule Martin, Hildebrandt Gerhard, Fournier Jean-Yves
Department of Neurosurgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.
J Neurol Surg A Cent Eur Neurosurg. 2016 Jul;77(4):300-7. doi: 10.1055/s-0035-1567861. Epub 2016 Apr 18.
Objective To evaluate clinical and radiologic outcome in patients treated with a dynamic cervical implant (DCI) or anterior cervical diskectomy and fusion (ACDF). Study Design A prospective comparative cohort study. Methods The study included 60 patients with one- or two-level cervical degenerative disk disease (DDD) undergoing treatment with either DCI (n = 30) or ACDF (n = 30). Clinical and radiologic outcomes were assessed 3 and 12 months after surgery. Clinical scoring systems included the Visual Analog Scale for Neck (VAS-N) and Arm pain (VAS-A), the Neck Pain and Disability Scale (NPAD), and the European Quality of Life Scale (EQ-5D). Results Both the DCI and ACDF group showed significant clinical improvement 12 months after surgery using the VAS-N (p = 0.034 and p < 0.001, respectively), VAS-A (p < 0.001 and p < 0.001, respectively), NPAD (p < 0.001 and p < 0.001, respectively), and EQ-5D (p < 0.001 and p < 0.001, respectively). There were no significant differences in clinical outcome comparing both groups at the 3- and 12-month follow-up. The fusion rate at 12 months after surgery was 39.4% and 80.0% in the DCI and ACDF groups, respectively. Radiolucency was found in 90.9% in the DCI group at 12-month follow-up. Conclusion The clinical results for DCI treatment are equivalent to those for ACDF in the treatment of one- and two-level cervical DDD at 12 months after surgery. Further studies are necessary to investigate the high rates of radiolucency and fusion associated with DCI treatment.
评估接受动态颈椎植入物(DCI)或颈椎前路椎间盘切除融合术(ACDF)治疗的患者的临床和影像学结果。研究设计:一项前瞻性比较队列研究。方法:该研究纳入60例患有单节段或双节段颈椎退行性椎间盘疾病(DDD)的患者,分别接受DCI治疗(n = 30)或ACDF治疗(n = 30)。在术后3个月和12个月评估临床和影像学结果。临床评分系统包括颈部视觉模拟量表(VAS-N)和手臂疼痛视觉模拟量表(VAS-A)、颈部疼痛和残疾量表(NPAD)以及欧洲生活质量量表(EQ-5D)。结果:使用VAS-N(分别为p = 0.034和p < 0.001)、VAS-A(分别为p < 0.001和p < 0.001)、NPAD(分别为p < 0.001和p < 0.001)以及EQ-5D(分别为p < 0.001和p < 0.001)评估,DCI组和ACDF组在术后12个月时均显示出显著的临床改善。在3个月和12个月的随访中,两组的临床结果无显著差异。术后12个月时,DCI组和ACDF组的融合率分别为39.4%和80.0%。在12个月的随访中,DCI组有90.9%出现透亮区。结论:在治疗单节段和双节段颈椎DDD时,DCI治疗在术后12个月的临床结果与ACDF相当。有必要进一步研究DCI治疗相关的高透亮区率和融合情况。